PATHWAY-2: which agent can best treat therapy resistant hypertension?Aug. 31, 2015 - ESC - Londen 2015 - Bryan Williams
Recorded at ESC 2015, August 31, 2015 in London, United Kingdom
Prof. Bryan Williams (University College London, United Kingdom)
Prof. Bryan Williams (Londen) presented the PATHWAY-2, in which 3 different additional agentsto treat therapy resistant hypertension were compared. Spironalactone clearly performed better than the other two.